LICR News
Prix Joseph Maisin attribué au DR. B. Van Den Eynde
22/10/10 16:34
Les Prix scientifiques quinquennaux du F.R.S.-FNRS,
pour la période 2006-2010, viennent d’être décernés.
Ces Prix prestigieux, attribués tous les cinq ans, sont
destinés à confirmer la reconnaissance internationale
et couronner l’excellence de la carrière de chercheurs
de la Communauté française de Belgique, dans toutes les
disciplines scientifiques. More...
LICR Ranks in Top 10 in World
01/02/10 10:00
The SCImago Institutions Ranking World Report 2009
ranks the best 2000 worldwide research institutions and
organizations and analyzes its research performance in
the period over five global indicators of output,
collaboration and scientific impact. More...
Thierry Boon steps down as Branch Director
01/01/10 10:21
Thierry Boon, PH.D., steps down as Branch
Director. More...
Laure Dumoutier appointed Assistant Member
15/12/09 10:07
Laure Dumoutier has been appointed as Assistant Member
at the Brussels Branch.
More...
More...
Stefan Constantinescu appointed Member
10/12/09 12:44
Stefan Constantinescu has been appointed as
Member at the Brussels Branch. More...
DR. B Van Den Eynde : Director-Designate of LICR BRUSSELS Branch
28/06/08 13:27
The LICR Board of Directors has appointed Benoît Van
den Eynde, M.D., Ph.D., Director-Designate of the LICR
Brussels Branch.
Dr. Thierry Boon, the Founding Director of the Branch, announced last year that he wouldstep down as director at the end of the year 2009.
The Board's appointment of Dr. Van den Eynde was made following external review and a recommendation from the Scientific Director and the President. More...
Dr. Thierry Boon, the Founding Director of the Branch, announced last year that he wouldstep down as director at the end of the year 2009.
The Board's appointment of Dr. Van den Eynde was made following external review and a recommendation from the Scientific Director and the President. More...
Research paper at the front page of "Immunity"
06/04/08 17:34
Research paper published in Volume 28 of Immunity by
Demotte N and van der Bruggen P made the
cover of the March 2008 issue of Immunity.
The paper called "Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes." can be accessed from the Immunity web site More...
The paper called "Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes." can be accessed from the Immunity web site More...
Dr B. Van Den Eynde received GlaxoSmithKline prize
15/11/07 10:34
The prize, awarded under the auspices of the two Royal
Academies of Belgium, is one
of the most important ones granted by a private corporation. Dr. Van den
Eynde receives the Francophone prize for the period 2004-2006 for his group's
discovery of a brand new mechanism for processing of antigenic peptides.
More...
of the most important ones granted by a private corporation. Dr. Van den
Eynde receives the Francophone prize for the period 2004-2006 for his group's
discovery of a brand new mechanism for processing of antigenic peptides.
More...
Le 4ème belge de la National Academy of Sciences (USA)
03/05/07 16:30
Thierry Boon Falleur a été élu, depuis le 1er mai,
membre effectif de la très prestigieuse National
Academy of Sciences (NAS) des Etats-Unis.
Même si la vénérable institution, créée en 1863 par le président Lincoln, compte quelques 2300 membres dont 350 étrangers, on n'entre pas là comme dans un moulin. More...
Même si la vénérable institution, créée en 1863 par le président Lincoln, compte quelques 2300 membres dont 350 étrangers, on n'entre pas là comme dans un moulin. More...
GlaxoSmithKline has licensed tumor-specific antigens from LICR
04/06/06 15:20
LICR and GlaxoSmithKline (GSK), the world's
second-largest pharmaceutical company, have announced
the signing of an agreement whereby GSK has licensed a
substantial portfolio of tumor-specific antigens from
LICR.
This licensing agreement follows a long-standing collaboration between both parties - specifically with the team led by Dr. Thierry Boon (Director, Brussels Branch). More...
This licensing agreement follows a long-standing collaboration between both parties - specifically with the team led by Dr. Thierry Boon (Director, Brussels Branch). More...
US National Academy honors for Dr. Thierry Boon
24/04/06 14:59
Dr. Thierry Boon, Director of the Branch, has been
elected as a Foreign Associate of the National Academy
of Sciences USA. More...
Inducing Melanoma for Cancer Vaccine Development
26/03/06 17:18
Cancer vaccines are being investigated in early-phase
clinical trials around the world, with many of those
trials recruiting patients with melanoma. Although
tumor regressions have been seen in 10% to 20% of
patients with metastatic melanoma, the great promise of
cancer vaccines - controlling tumor growth and cancer
spread without serious side-effects - remains as yet
unrealized. This could be set to change with the
publication of a new mouse model technology from a
multi-national team led by investigators at the
Brussels Branch of the international Ludwig Institute
for Cancer Research (LICR). More...